This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Non-canonical NF-κB drives a fate switch from germinal center to early effector B cells.
iScience · 2026 · senior author
SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities.
Cancer discovery · 2026
Phenotypic Characterization and Prognostic Impact of CD103+ Tissue-Resident Memory T Cells in Diffuse Large B-cell Lymphoma.
Cancer immunology research · 2026
Latest funding
- $1,453,500
Common precursor cells in diffuse large B-cell lymphoma: characterization, evolutionary trajectories and clinical applications.
CIHR · 2025 · Co-investigator
- $1,139,850
Self reactivity as a driver of extranodal diffuse large B-cell lymphoma transformation and progression.
CIHR · 2021 · Nominated PI
8 publications.
Non-canonical NF-κB drives a fate switch from germinal center to early effector B cells.
Nawaz W, Fong A, Cardoso MP, Tang J, Zhao J, Li MY, Rai S, Beresford A, Alduaij W, Boyle M, Steidl C, Scott DW, Venturutti L
SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities.
Pelzer B, Meydan C, Spiegel IM, Karagiannidis I, Xia M, Teater M, Welter EM, Searcy ZE, Hilton LK, Barisic D, Fong A, Fa P, Sethi S, Isgor IS, Fielding JJ, Karbalayghareh A, Burdette CS, Tumuluru S, Debek SM, Lee S, Massoni-Badosa R, Durmaz C, Salataj E, Pararajalingam P, Chen Z, Pelzl RJ, Shah S, Rivas MA, Hoehn KB, Mlynarczyk C, Isles HM, Wang X, Dogan A, Elenitoba-Johnson KSJ, Scott DW, Dreval K, Morin RD, Leslie CS, Puri R, Geri JB, Chin CR, Chadburn A, Mason CE, Reinhardt HC, Anguera MC, Béguelin W, Venturutti L, Melnick AM
Phenotypic Characterization and Prognostic Impact of CD103+ Tissue-Resident Memory T Cells in Diffuse Large B-cell Lymphoma.
Savage G, Milne K, Collinge B, Yin Y, Loos P, Warren ME, Laumont CM, Keith D, Nelson BH, Venturutti L, Weng AP, Scott DW, Steidl C, Evgin L
T follicular helper cells transiently unlock a plasticity state in germinal centre B cells during the humoral immune response.
Scourzic L, Izzo F, Teater M, Polyzos AP, Cucereavii L, Chin CR, Papin A, Pinto HB, Mlynarczyk C, Tsialta I, Xia M, Lidoski A, Myers RM, Israel EM, Venturutti L, Mackay SP, Hoehn KB, Skoultchi AI, Béguelin W, Stadtfeld M, Chen Z, Landau DA, Melnick AM, Apostolou E
Somatic IRF4 mutations and thymic tropism in primary mediastinal large B-cell lymphoma.
Rai S, Duns G, Frontzek F, Wong JCH, Yin Y, Li MY, Kishida M, Fujisawa M, Healy S, Viganò E, Jiang A, Woolcock B, Telenius A, Ben-Neriah S, Meissner B, Boyle M, Nakamura H, O'Brien L, Cassidy C, Lytle A, Farinha P, Slack G, Hilton LK, Morin RD, Venturutti L, Aoki T, Wretham N, Bush JW, Evgin L, Savage KJ, Scott DW, Steidl C
Profiling Dynamic Patterns of Single-Cell Motility.
Maity D, Sivakumar N, Kamat P, Zamponi N, Min C, Du W, Jayatilaka H, Johnston A, Starich B, Agrawal A, Riley D, Venturutti L, Melnick A, Cerchietti L, Walston J, Phillip JM
TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma.
Li MY, Chong LC, Duns G, Lytle A, Woolcock B, Jiang A, Telenius A, Ben-Neriah S, Nawaz W, Slack GW, Elisia I, Viganò E, Aoki T, Healy S, Krystal G, Venturutti L, Scott DW, Steidl C
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas.
Venturutti L, Rivas MA, Pelzer BW, Flümann R, Hansen J, Karagiannidis I, Xia M, McNally DR, Isshiki Y, Lytle A, Teater M, Chin CR, Meydan C, Knittel G, Ricker E, Mason CE, Ye X, Pan-Hammarström Q, Steidl C, Scott DW, Reinhardt HC, Pernis AB, Béguelin W, Melnick AM
Common precursor cells in diffuse large B-cell lymphoma: characterization, evolutionary trajectories and clinical applications.
Principal investigators: Scott, David W
Keywords: Classification Systems; Common Precursor Cells; Tumour Evolution
Self reactivity as a driver of extranodal diffuse large B-cell lymphoma transformation and progression.
Principal investigators: Venturutti, Leandro
Keywords: Autochthonous Mouse Models; B-Cell Lymphoma; Biomarkers; Extranodal Disease; Immune Niche; Malignant Transformation; Novel Therapeutics; Self-Reactivity; Signaling Cascades; Toll-Like Receptors
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Experimental Therapeutics
- Other
Co-authors at University of British Columbia, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.